Moreover, the protein complex formed by HOXA9 and C/EBPα targeted Cdkn2a/b to overcome G1 phase blockage, promoted the proliferation of bone marrow cells and advanced the process of myeloid leukemia [47]. This evidence concerns the gene CDKN2A and myeloid leukemia.